K. Hamamoto

发表

Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.

N. Kamada, H. Asou, S. Tashiro, 1991 .

Clinical and Genetic Characteristics of XIAP Deficiency in Japan

H. Kanegane, T. Miyawaki, T. Imamura, 2012, Journal of Clinical Immunology.

Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia Study (JACLS) ALL F‐protocol

K. Horibe, T. Nakahata, H. Hori, 2010, Pediatric blood & cancer.

Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation.

K. Okamura, S. Ogawa, Motohiro Kato, 2018, Cancer research.

Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

K. Kawa, H. Shimada, A. Yoshimi, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic‐phase chronic myeloid leukemia treated with imatinib

H. Shimada, S. Mizutani, K. Horibe, 2017, Pediatric blood & cancer.

Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.

N. Kamada, H. Asou, S. Tashiro, 1991, Blood.

Improved Outcome of Combination Therapy with ATRA, Anthracyclines and Cytarabine, AML99-M3 Protocol, for Childhood Acute Promyelocytic Leukemia.

R. Hanada, K. Horibe, M. Imaizumi, 2005 .

Fluorescence in situ Hybridization Analysis of 12;21 Translocation in Japanese Childhood Acute Lymphoblastic Leukemia

M. Eguchi, N. Kamada, M. Ohki, 1998, Japanese journal of cancer research : Gann.

Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.

R. Hanada, K. Horibe, M. Imaizumi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

with 8 ; 21 chromosome translocation Establishment of a human acute myeloid leukemia cell line ( Kasumi-1 )

N. Kamada, H. Asou, S. Tashiro, 2003 .

Establishment of a myeloid leukaemia cell line (Kasumi‐4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis

M. Eguchi, N. Kamada, Kimio Tanaka, 1996, British journal of haematology.

Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in Transformation (RAEB‐T) in the Japanese MDS99 study

J. Okamura, T. Nakahata, S. Kojima, 2012, British journal of haematology.

Sequential use of second‐generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group

H. Shimada, S. Mizutani, K. Horibe, 2018, Pediatric blood & cancer.

Ring/marker chromosome derived from chromosome 7 in childhood acute megakaryoblastic leukemia with monosomy 7

S. Adachi, T. Heike, Kenichiro Watanabe, 2010, International journal of hematology.

Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol

Y. Hayashi, R. Hanada, K. Horibe, 2014, International Journal of Hematology.

Azacitidine successfully maintained the second remission in an infant with KMT2A‐rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation

M. Eguchi, S. Nishimura, K. Hamamoto, 2017, Pediatric blood & cancer.

Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.

A. Fischer, H. Kanegane, P. Veys, 2013, Blood.

Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children

H. Shimada, S. Ohga, S. Kojima, 2014, Annals of Hematology.

Clinical features and outcome of X‐linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis

H. Kanegane, T. Miyawaki, Y. Nakazawa, 2012, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS

K. Horibe, T. Hongo, N. Suzuki, 2002, Pediatrics international : official journal of the Japan Pediatric Society.

High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS)

K. Horibe, Yoshiyuki Takahashi, A. Hayakawa, 2019, International Journal of Hematology.

Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan

H. Kanegane, T. Morio, M. Takagi, 2016, Journal of Clinical Immunology.

Clinical and Genetic Characteristics of XIAP Deficiency in Japan

H. Kanegane, T. Miyawaki, T. Imamura, 2012, Journal of Clinical Immunology.

Hematopoietic cell transplantation rescues inflammatory bowel disease and dysbiosis of gut microbiota in XIAP deficiency.

M. Hattori, O. Ohara, K. Honda, 2021, The journal of allergy and clinical immunology. In practice.

Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia

S. Okada, K. Hamamoto, Y. Nishi, 2011, International journal of hematology.